The Seal of Acceptance of the American Dental Association's Council on
Dental Therapeutics has been awarded to Listerine and chlorhexidine g
luconate (Peridex). The mechanism of action of Listerine involves bact
erial cell wall destruction, bacterial enzymatic inhibition, and extra
ction of bacterial lipopolysaccharides. Chlorhexidine has the property
of substantivity, i.e. the ability to bind to hard and soft tissue wi
th slow release. Antibacterial mouthrinses/dentifrices containing tric
losan hold promise for the reduction of plaque and gingivitis but are
not yet available in the United States. The quaternary ammonium compou
nds and sanguinarine compounds (Viadent) have some merit, but studies
of their efficacy in plaque and gingivitis reduction are mixed. New pr
oducts containing various fluorides and oxygenating agents may have Po
tential for the future as antiplaque and antigingivitis agents.